blue- At this point I wonder if Boyd just plans to buy company out on the cheap and take the tech. I really don't see anything that leads me to believe he has other plans. Maybe news will come soon, showing me differently... Not yet though... I said long ago that Odidi belongs in University academia. Where you get grants to conduct research and no one expects anything. Him and his wife like to play scientist in the lab and file for patents. The problem I told Patient the company had when he came on board was that IPCI never monetizes any of its tech. That is still the case. If Odidi thinks he can couple a R/S with dilution to save company, he is sorely mistaken. If he attempts that, the company will be sold off on the cheap.
We've often wondered just what all 50+ IPCI employees do all day every day right bluelucky! There's simply gotta be progress being made behind the scenes on a number of fronts the market doesn't even know about...otherwise IPCI still wouldn't have so many employees hard at work each day!